Shares of Indivior PLC (LON:INDV – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 712.52 ($9.03) and traded as high as GBX 787.50 ($9.98). Indivior shares last traded at GBX 769 ($9.75), with a volume of 273,799 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,500 ($19.01) price objective on shares of Indivior in a research note on Thursday, September 5th.
Check Out Our Latest Research Report on Indivior
Indivior Trading Up 1.9 %
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- What Investors Need to Know to Beat the Market
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Applied Materials Market Capitulates: Now is the Time to Buy
- How to Use the MarketBeat Stock Screener
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.